程序性细胞死亡配体1在一例低分化富淋巴细胞型肝细胞癌中的表达

Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma.

作者信息

Omori Ginji, Osuga Takahiro, Miyanishi Koji, Hamaguchi Kota, Tanaka Shingo, Ohnuma Hiroyuki, Murase Kazuyuki, Takada Kohichi, Nagayama Minoru, Kimura Yasutoshi, Takemasa Ichiro, Kikuchi Yasuhiro, Torigoe Toshihiko, Kato Junji

机构信息

Department of Medical Oncology Sapporo Medical University School of Medicine Sapporo Japan.

Department of Infection Control and Laboratory Medicine Sapporo Medical University School of Medicine Sapporo Japan.

出版信息

Clin Case Rep. 2021 Sep 9;9(9):e04764. doi: 10.1002/ccr3.4764. eCollection 2021 Sep.

Our pathological study of a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma suggested that immune checkpoint inhibitor may be an effective therapy. The histological type is an important factor in determining treatment choices.